Aspiriant LLC’s Vanguard Total International Stock ETF VXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$854K Buy
9,982
+292
+3% +$24.5K 0.02% 187
2026
Q1
$747K Buy
9,690
+685
+8% +$54.4K 0.02% 182
2025
Q4
$679K Sell
9,005
-26,124
-74% -$1.95M 0.02% 187
2025
Q3
$2.58M Hold
35,129
0.08% 88
2025
Q2
$2.43M Buy
35,129
+27,323
+350% +$1.77M 0.08% 91
2025
Q1
$485K Buy
7,806
+3,157
+68% +$195K 0.02% 193
2024
Q4
$274K Hold
4,649
0.01% 244
2024
Q3
$301K Buy
4,649
+1
+0% +$62 0.01% 232
2024
Q2
$280K Hold
4,648
0.01% 242
2024
Q1
$280K Hold
4,648
0.01% 257
2023
Q4
$269K Hold
4,648
0.01% 256
2023
Q3
$249K Buy
4,648
+488
+12% +$27.2K 0.01% 248
2023
Q2
$233K Sell
4,160
-1,760
-30% -$98.4K 0.01% 257
2023
Q1
$327K Sell
5,920
-5,054
-46% -$276K 0.02% 211
2022
Q4
$568K Buy
+10,974
New +$549K 0.03% 167
2022
Q2
Sell
-6,072
Closed -$363K 291
2022
Q1
$363K Buy
+6,072
New +$370K 0.02% 202

Other funds holding VXUS

Aspiriant LLC's VXUS Position: Q2 2026 in Review

Aspiriant LLC increased its Vanguard Total International Stock ETF (VXUS) stake by 3% in Q2 2026, buying an estimated $24.5K and bringing the position to 9,982 shares worth $854K. The position accounts for 0.02% of the portfolio, ranked #187.

Aspiriant LLC first reported a position in VXUS in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.58M in Q3 2025. 1,840 funds tracked by Wall St. Rank hold VXUS as of Q2 2026.

  • Aspiriant LLC held 9,982 shares of Vanguard Total International Stock ETF worth $854K as of Q2 2026.
  • Aspiriant LLC bought 292 Vanguard Total International Stock ETF shares in Q2 2026, an estimated $24.5K.
  • Vanguard Total International Stock ETF made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #187 holding.
  • Aspiriant LLC first reported a position in Vanguard Total International Stock ETF in Q1 2022 and has held it in 16 quarters since.
  • Aspiriant LLC's Vanguard Total International Stock ETF position peaked at $2.58M in Q3 2025.
  • 1,840 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.